For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

Health Library

 
Browse A-Z
Search
    test
    test
    test
Print-Friendly
Bookmarks
bookmarks-menu

Antiretroviral medications - reverse transcriptase inhibitors

Reverse transcriptase inhibitors include:

  • Ribavirin (Copegus and Rebetol)
  • Entecavir (Baraclude)
  • Adefovir (Hepsera)
  • Tenofovir(Viread)
  • Abacavir(Ziagen)
  • Emtricitabine(Emtriva)
  • Zidovudine (Retrovir)
  • Didanosine (Videx)
  • Zalcitabine (Hivid)
  • Stavudine (Zerit)
  • Lamivudine (Epivir)
 

Depletions

There is no evidence that these medications deplete any nutrients.

Editorial Note

The information presented here covers some of the nutrients that may be affected when you take certain medications. If you have the signs and symptoms listed, it does not always mean you have low levels of these nutrients. Many things affect the level of nutrients, including your:

  • Medical history
  • Diet
  • Lifestyle

As well as how long you have been taking the medication. Please talk with your health care provider. They can best address your health care needs and determine whether you are at risk for low levels of any nutrients.

Supporting Research

Gold Standard Drug Database: Drug Monograph: Abacavir, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-2332. Accessed July 19, 2016.

Gold Standard Drug Database: Drug Monograph: Adefovir, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-2233. Accessed July 19, 2016.

Gold Standard Drug Database: Drug Monograph: Didanosine, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-186. Accessed July 7, 2016.

Gold Standard Drug Database: Drug Monograph: Emitricitabine, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-2465. Accessed July 19, 2016.

Gold Standard Drug Database: Drug Monograph: Entecavir, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-3427. Accessed July 19, 2016.

Gold Standard Drug Database: Drug Monograph: Lamivudine, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-339. Accessed July 7, 2016.

Gold Standard Drug Database: Drug Monograph: Ribavirin, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-542. Accessed July 7, 2016.

Gold Standard Drug Database: Drug Monograph: Stavudine, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-573. Accessed July 7, 2016.

Gold Standard Drug Database: Drug Monograph: Tenofovir, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-2477. Accessed July 19, 2016.

Gold Standard Drug Database: Drug Monograph: Zalcitabine, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-652. Accessed July 7, 2016

Gold Standard Drug Database: Drug Monograph: Zidovudine, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-653. Accessed July 7, 2016.

hide

 

 

 

Review Date: 9/19/2016  

Reviewed By: Steven D. Ehrlich, NMD, Solutions Acupuncture, a private practice specializing in complementary and alternative medicine, Phoenix, AZ. Review provided by VeriMed Healthcare Network. Also reviewed by the A.D.A.M. Editorial team.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com

A.D.A.M. content is best viewed in IE9 or above, Firefox and Google Chrome browser.
Content is best viewed in IE9 or above, Firefox and Google Chrome browser.